UTERINE CARCINOSARCOMA

Clinical trials for UTERINE CARCINOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new UTERINE CARCINOSARCOMA trials appear

Sign up with your email to follow new studies for UTERINE CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug combo shows promise for rare, aggressive uterine cancer

Disease control Ongoing

This study tests whether combining two drugs, pembrolizumab and lenvatinib, can shrink tumors or slow cancer growth in people with advanced uterine or ovarian carcinosarcoma, a rare and aggressive cancer. About 40 participants will receive the treatment, and researchers will also…

Matched conditions: UTERINE CARCINOSARCOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

UTERINE CARCINOSARCOMA

Get alerted when new UTERINE CARCINOSARCOMA trials appear

New drug combo shows promise for rare, aggressive uterine cancer